BioSpace News Archive

IDEXX Laboratories, Inc. announces the launch of the IDEXX inVue Dx™ Cellular Analyzer, a first-of-its-kind slide-free cellular analyzer to detect the most common cytologic changes found in ear and blood samples.

PharmaLogic Holdings Corp. and ARTBIO today announce a manufacturing and supply agreement for ARTBIO’s lead-212 (212Pb) based radiopharmaceutical candidate, AB001, for the treatment of prostate cancer.

Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities General Regulation, Innate Pharma SA releases its total number of shares outstanding as well as its voting rights as at January 1, 2024.

RemeGen Co. Ltd. announced recently that its independently developed mesothelin -targeting antibody-drug conjugate, RC88, has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of platinum-resistant recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers.

SimBioSys is pleased to announce the strategic appointment of Dr. Barry Rosen as its Chief Medical Officer.